Mar 30, 2020 — 7 min read
Lunit, a medical AI software company that develops AI-powered analysis of lung diseases via chest x-ray images, today announced that it will be releasing its software online, free of charge, to help healthcare professionals manage coronavirus.
Coronavirus is known to cause pneumonia, which can be found as “consolidation” on chest x-ray images. The software, developed by Lunit, is an AI solution for chest x-ray analysis, detecting 10 different radiologic findings including lung nodule, consolidation, and more with 97-99% accuracy. For the online release, the company is providing consolidation findings only, which is suggestive of coronavirus-related pneumonia.
“We hope our decision to publicly release a special version of our software can help ease the strain in the healthcare system in countries around the world,” said Brandon Suh, CEO of Lunit. “Our AI solution has been in use at coronavirus care centers in South Korea, which is one of the countries that are successfully “flattening the curve” by applying diverse and innovative measures in the battle against the virus.”
In South Korea, Lunit INSIGHT CXR has been deployed to assist the diagnosis of COVID-19 patients from Daegu and nearby region, the hardest-hit area where approximately 8,000 patients—about 85% of the entire domestic cases—has been diagnosed. Seoul National University Hospital has built a coronavirus care center in Daegu, where physicians remotely examine patients via video call.
The patients’ chest x-ray images are sent directly to radiologists in Seoul, where Lunit INSIGHT CXR is used to support the radiologists in the management of COVID-19. The system helps healthcare professionals in the prompt and early discovery of patients, sending them directly to larger hospitals for proper treatment if required.
Beyond South Korea, Lunit INSIGHT CXR has also been installed at PreventSenior, one of the largest hospital networks in Brazil with 8 locations throughout the metropolitan region of Sao Paulo. PreventSenior is one of the COVID-19 detection centers that use chest x-ray screening for patients with mild symptoms.
In March, PreventSenior has deployed Lunit INSIGHT CXR for the analysis of more than 3,000 chest x-ray images suspected of coronavirus infection. The doctors at PreventSenior says that Lunit INSIGHT CXR is providing great help “especially for patient triage,” as the hospital is “overflowing with patients while the number of radiologists remains low.”
Physicians and radiologists working at Lunit suggest that the AI may be used as a supportive tool during case overload, which can likely lead to low reading quality, or with portable x-ray devices to fast-track test results and decision-making in advance to the PCR results, which is the test for a definitive diagnosis for coronavirus.
Lunit INSIGHT CXR can also assist when regular monitoring is required for patients showing mild symptoms, in order to identify and triage patients by the progression and regression of symptoms.
“The current coronavirus epidemic is burdening health care providers around the world with massive demands for tests, diagnosis, and treatment,” said Ki Hwan Kim, Chief Medical Officer of Lunit. “While PCR is used to make a definitive diagnosis for coronavirus, chest x-ray can also be a fast, effective, and affordable test to evaluate coronavirus-related pneumonia, but the massive shortage of interpreting radiologists exists as a hurdle. AI can provide assistance.”
According to Lunit’s recent internal study, Lunit INSIGHT CXR is able to detect coronavirus pneumonia in the level of radiologists. In the study, anteroposterior chest X-rays (CXRs) of 6 patients confirmed to have coronavirus disease-19 (COVID-19) at the time of admission were retrospectively analyzed by Lunit INSIGHT CXR. Both radiologists and AI correctly detected CXR abnormalities from x-ray images of three patients with clearly visible lesions. Neither radiologist nor AI was able to detect subtle or non-visible lesions from the other three patients.
“The AI can instantly interpret chest x-ray images to select suspicious cases that warrant further action to whether or not isolate the patient even before PCR confirmation,” said Kim. “Lunit INSIGHT CXR may be beneficial especially as a triage tool for non-radiologists, or even for non-doctors in extreme cases.”
In light of the current outbreak, Lunit has released a special version of Lunit INSIGHT CXR specific for coronavirus, at www.lunit.io/covid19. Anyone can upload chest x-ray DICOM image files and get real-time analysis results conducted by Lunit INSIGHT, for free, with coronavirus-related findings displayed by the algorithm as “consolidation.”
Lunit INSIGHT CXR, developed by Lunit, is a state-of-the-art AI solution for chest x-ray analysis, detecting 10 different radiologic findings including lung nodule, consolidation, and more with 97-99% accuracy. Lunit INSIGHT CXR is designed to help radiologists detect more and better, alleviating the burden coming from routine chest x-ray interpretations.
The software has received CE mark and has been featured in major publications such as Radiology, JAMA Network Open, European Radiology, and Clinical Infectious Diseases. As of March 2020, Lunit INSIGHT CXR has analyzed more than three million chest x-ray images from over 80 countries around the world.
Lunit wins Tumor Proliferation Assessment Challenge (TUPAC) 2016
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit to showcase AI-powered products at USCAP 2017
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit Unveils “Lunit INSIGHT,” A New Real-time Imaging AI Platform on the Web at RSNA 2017
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
Media Advisory: Lunit at RSNA 2018
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit to Present Abstracts on AI-powered Precision Pathology at 2019 AACR Annual Meeting
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit to Present Findings on the Predictive Power of AI Biomarker for Lung Cancer Immunotherapy at ASCO 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Lunit to Present Findings on the Predictive Power of AI-based Analysis of Immune Phenotype at ASCO 2020
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
AI Solution for COVID-19, Developed by Medical AI Firm Lunit, Now Has Users in More Than 10 Countries
Lunit Awarded as Technology Pioneer by World Economic Forum
Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations
Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?